Gregory Trudel - Encision CEO and President and Director

ECIADelisted Stock  USD 0.46  0.00  0.00%   

CEO

Mr. Gregory J. Trudel was appointed as President, Chief Executive Officer, Director of Encision Inc., effective December 23, 2013. He has over 25 years of experience in the surgical devices marketplace. Since 2008, Mr. Trudel was employed by Covidien, a large global healthcare products company. Most recently, Mr. Trudel served as Global Director of Marketing for a division within the Surgical Solutions Group at Covidien. His time at Covidien also includes extensive marketing and product management experience in Covidiens Advanced Energy and Surgical Stapling divisions. Prior to joining Covidien, Greg held leadership roles with ConMed Electrosurgery, SilverGlide Surgical Technologies, and Stryker since 2013.
Age 62
Tenure 11 years
Professional MarksMBA
Phone303 444 2600
Webhttps://www.encision.com
Trudel holds a B.S. from the University of Connecticut, Storrs, CT and an M.B.A from the University of Bridgeport, Bridgeport, CT.

Encision Management Efficiency

The company has return on total asset (ROA) of (0.0831) % which means that it has lost $0.0831 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.2203) %, meaning that it created substantial loss on money invested by shareholders. Encision's management efficiency ratios could be used to measure how well Encision manages its routine affairs as well as how well it operates its assets and liabilities.
The company currently holds 206 K in liabilities with Debt to Equity (D/E) ratio of 0.35, which is about average as compared to similar companies. Encision has a current ratio of 3.19, suggesting that it is liquid enough and is able to pay its financial obligations when due. Debt can assist Encision until it has trouble settling it off, either with new capital or with free cash flow. So, Encision's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Encision sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Encision to invest in growth at high rates of return. When we think about Encision's use of debt, we should always consider it together with cash and equity.

Similar Executives

Found 14 records

CEO Age

James BernauWillamette Valley Vineyards
70
Eduardo SilvaFomento Economico Mexicano
62
Bernardo PaivaAmbev SA ADR
45
Carlos LomelinFomento Economico Mexicano
66
Carlos BritoAnheuser Busch Inbev
60
Joao NevesAmbev SA ADR
N/A
John OtazuaFomento Economico Mexicano
62
Alfonso GarzaFomento Economico Mexicano
62
Brendan WhitworthAnheuser Busch Inbev
45
Margaret GeorgiadisMattel Inc
52
Daniel CofreFomento Economico Mexicano
54
Jean NetoAmbev SA ADR
50
Jose BoisjoliBRP Inc
66
Ynon KreizMattel Inc
59
Encision Inc., a medical device company, designs, develops, manufactures, and markets patented surgical instruments in the United States. Encision Inc. was incorporated in 1991 and is based in Boulder, Colorado. Encision operates under Medical Instruments Supplies classification in the United States and is traded on OTC Exchange. It employs 31 people. Encision [ECIA] is a Pink Sheet which is traded through a dealer network over-the-counter (OTC). Encision is listed under Medical Equipment category by Fama And French industry classification.

Management Performance

Encision Leadership Team

Elected by the shareholders, the Encision's board of directors comprises two types of representatives: Encision inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Encision. The board's role is to monitor Encision's management team and ensure that shareholders' interests are well served. Encision's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Encision's outside directors are responsible for providing unbiased perspectives on the board's policies.
Brad Greathouse, Vice President - Regulatory Affairs & Quality Assurance
Michael Biggs, VP of Engineering
Peter Geary, Vice President - Operations
Mala Ray, Controller, Treasurer and Corporate Secretary
Gregory Trudel, CEO and President and Director
Valerie Ray, VP of Operations
Brian Jackman, VP Marketing
Robert Fries, Independent Director
Ruediger NaumannEtienne, Independent Director
Patrick Pace, Executive Chairman of the Board
David Newton, Co-Founder, VP of Technology and Director
Vern Kornelsen, Independent Director

Encision Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is Encision a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Pair Trading with Encision

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Encision position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Encision will appreciate offsetting losses from the drop in the long position's value.

Moving against Encision Pink Sheet

  0.58NEPH NephrosPairCorr
  0.56MMSI Merit Medical Systems Financial Report 24th of April 2024 PairCorr
  0.48NVST Envista Holdings Corp Financial Report 1st of May 2024 PairCorr
  0.48WRBY Warby Parker Financial Report 14th of May 2024 PairCorr
The ability to find closely correlated positions to Encision could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Encision when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Encision - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Encision to buy it.
The correlation of Encision is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Encision moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Encision moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Encision can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in gross domestic product.
You can also try the Correlation Analysis module to reduce portfolio risk simply by holding instruments which are not perfectly correlated.

Other Consideration for investing in Encision Pink Sheet

If you are still planning to invest in Encision check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Encision's history and understand the potential risks before investing.
Global Correlations
Find global opportunities by holding instruments from different markets
Bonds Directory
Find actively traded corporate debentures issued by US companies
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets